# A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis

> **NCT01903798** · PHASE2 · COMPLETED · sponsor: **Southern California Institute for Research and Education** · enrollment: 4 (actual)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** Mycophenolate mofetil
- **DRUG:** Prednisolone
- **DRUG:** Rilonacept

## Key facts

- **NCT ID:** NCT01903798
- **Lead sponsor:** Southern California Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01903798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01903798, "A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01903798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*